A 31-year-old woman, who is a known case of polycystic ovary syndrome, underwent modified radical hysterectomy and right ovarian transposition to the anterior abdominal wall for endometrioid adenocarcinoma Grade II. She then visited our facility for in vitro fertilization (IVF) and surrogacy in the year 2016. Three cycles of IVF were performed using gonadotropin-releasing hormone (GnRH) antagonist in the first two attempts and GnRH agonist in the third attempt, with percutaneous technique of oocyte retrieval from the transpositioned right ovary. In the third attempt in July 2017, we were able to retrieve five oocytes and subsequently froze three embryos and one blastocyst. The surrogate underwent sequential transfer in June 2018 which resulted in a positive clinical singleton pregnancy. The outcome of IVF following percutaneous oocyte retrieval led to a successful pregnancy and subsequent delivery by emergency cesarean by a healthy female baby on February 16, 2019. This is the first reported case of ovarian hyperstimulation and percutaneous aspiration of oocytes from a transpositioned right ovary (subcutaneous plane) in our country. Global literature survey revealed publications only of transabdominal retrieval of ovaries moved above the pelvic brim.
Introduction

O
varian transposition seems to be the most logical step in young women of reproductive age group who may need to undergo radiation following a diagnosis of cancer cervix or endometrium. In this context, ovarian transposition to a location on the lateral pelvic peritoneal wall, just above the pelvic brim after securing the vascular pedicle, seems to be the most feasible, although there may not be a complete protection from scatter radiation. However, this technique is commonly practiced.
We present an interesting case report of a successful pregnancy arising from oocyte retrieval, performed percutaneously from an ovary placed in the subcutaneous plane of the anterior abdominal wall, above the rectus sheath. Journal of Human Reproductive Sciences ¦ Volume 12 ¦ Issue 3 ¦ July-September 2019 salpingo-oophorectomy and complete pelvic clearance in addition to a right ovary transposition to the anterior abdominal wall (subcutaneous plane) on July 21, 2014.
Her subsequent histopathological report revealed a less-than-half involvement of the myometrium with absence of any local or distal spread, ascites or positive pelvic or para-aortic lymphadenopathy. She was estrogen receptor and progesterone receptor positive and human epidermal receptor-2 Neu negative. Hence, the oncology team decided to defer radiation and opted to follow her up every few months. A computed tomography scan done a year later (July 13, 2015) revealed a normal study with a functioning right ovary with preserved vascularization and presence of multiple hypodense follicles on its surface. No other abnormal findings were noted.
At our hospital, we performed a comprehensive master health checkup, inclusive of a sonomammogram, vault smear, and ultrasound, which were found to be normal. The ultrasound revealed an ovarian size of 3.6 cm × 3.4 cm located on the right side of the abdomen, within the subcutaneous plane. The antral follicle count was eight. Her hormone values were consistent with PCOS, namely follicle-stimulating hormone (FSH) 9.52 mIU/ml, luteinizing hormone 12.43 mIU/ml, serum prolactin 8.55 mIU/ml, and anti-Mullerian hormone 4.6 ng/ml. The treatment plan was drawn, whereby she would consume a month of oral contraceptive pills and then undergo hormone evaluation on an assumed day 2/3 rd of the cycle. This would be followed by stimulation for a short protocol using a combination of recombinant FSH and human menopausal gonadotropin along with an antagonist.
After adequate counseling and informed consent from the couple, three cycles were attempted (the last one with agonist), with a gap of few months between each hyperstimulation, the summary of which is provided in Table 1 . In the first attempt, a pregnancy was achieved in a surrogate after the retrieval of one oocyte, which was fertilized and transferred on day 3, but, unfortunately, ended in a missed miscarriage. The second attempt yielded six oocytes, of which only three were mature oocytes and were injected; only one fertilized and cleaved, and a day-3 transfer in a surrogate yielded a negative result.
We initiated her 3 rd cycle using a short protocol with gonadotropin-releasing hormone agonist (injection Gonapeptyl, Ferring Pharmaceuticals Pvt Ltd., Thane, India) and recombinant FSH (Recagon, Organon [India] Private Limited, Thane, India) along with gonadotropins (in vitro fertilization-M, LG Life Sciences India Pvt Ltd., Haryana, India). When the maximum follicular size reached 1.8 cm × 1.8 cm, a human chorionic gonadotropin (hCG) trigger was given (injection Ovitrelle 250 µg, Merck Specialities Private Limited, Mumbai, India). Owing to the heterotopic site of location, oocyte retrieval was meticulously planned. We decided to use the th day which showed a single intrauterine gestational sac. Fetal heart pulsations were observed on the 45 th day. Her first-trimester screening (double marker with nuchal translucency) performed at 13 weeks of pregnancy, was normal. The antenatal period progressed uneventfully, and she delivered a healthy baby girl weighing 2.62 kg, on February 16, 2019. A general follow-up after a month showed normal development for age.
Discussion
Giacalone et al. [1] reported the first-ever case of pregnancy in a surrogate mother after stimulation of a transposed ovary following chemotherapy and pelvic irradiation. Following this, a series of pregnancies have [3] and Steigrad et al. [4] in 2005, making gestational surrogacy an important consideration in cancer patients who have undergone hysterectomy, as well as the technique of transabdominal oocyte retrieval.
Studies have shown that at a distance of about 3 cm from the pelvic inlet, the radiation received will be only 1%-10% of the total dose. Therefore, transposed ovaries possibly receive only 0.45-4.5 Gy of a total of 45 Gy, whereas retained ovaries could receive 20-32 Gy. [5] In our case, right ovarian transposition was done, placing the ovary in the right subcutaneous plane. Chitrathara et al. [6] described a simple technique of positioning the ovary in the anterior abdominal wall [ Figure 8 ]. In this technique, the ovary can be monitored easily and can be removed as an outpatient procedure whenever required. Similar to preparing for ovarian transposition outside the pelvis, the ovary with the pedicle is freed up to or beyond the pelvic brim. Pedicle length should be enough so as to bring it out without tension. The pedicle is brought out lateral to the cecum on the right side and lateral to the sigmoid-descending colon on the left side. Care is taken to ensure that the pedicle is not twisted. To facilitate easy bringing out and positioning of the ovary in the anterior abdominal wall, the fallopian tube is not removed earlier.
As suggested in the study by Giacalone et al., [1] this choice of location may entail complaints of pain following ovarian enlargement, which the patient did suffer from. Transposing ovaries to paracolic gutter seemed to be more common and had fewer complaints. However, in defense, our retrieval seemed far easier to perform as it was a percutaneous approach. However, as predictable with any transposition surgery, the ovarian response and quality of oocytes remain unpredictable. [7] We did not encounter any cyst formation or infection but only ovarian enlargement.
Our case had undergone open surgery and had the ovarian and infundibular pelvic vascular pedicle dissected and mobilized to elevate the right ovary with preserved blood supply to the subcutaneous plane. This too did not create any postprocedural issues. It remains, however, to be seen which method would work better -ovarian transposition to the lateral pelvic wall above the brim or to the subcutaneous plane.
Conclusion
This is the first-ever reported case of ovarian hyperstimulation and percutaneous aspiration of oocytes from a transpositioned right ovary in India. Global literature survey has shown published case reports of transabdominal aspiration for retrieval but none using percutaneous technique resulting in a successful pregnancy.
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